AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioNTech and InstaDeep to Host Second AI Day on October 1, 2025
ByAinvest
Tuesday, Sep 23, 2025 6:46 am ET1min read
BioNTech, a global immunotherapy company, will host its second AI Day on October 1, 2025, in London. The event will showcase the company's AI strategy and capabilities, as well as its application in the pipeline and internal processes. The live webcast will be available on BioNTech's website, and the recording will be archived for one year. The event is part of the company's Innovation Series.
BioNTech SE (NASDAQ: BNTX), a global biopharmaceutical company specializing in immunotherapy, has announced its second AI Day event as part of its Innovation Series. The event is scheduled for October 1, 2025, at 9:00 AM EDT in London. This event will provide insights into BioNTech's AI strategy and its applications in the company's pipeline and internal processes.The AI Day event will be accessible through a live webcast and will be available on BioNTech's Investor Relations website for one year following the event. The recording will be archived on the company's website for participants to review at their convenience. This event marks a significant milestone in BioNTech's continued focus on AI development, following their acquisition of InstaDeep Ltd. [1]
BioNTech's AI strategy is aimed at leveraging artificial intelligence to accelerate the development of novel biopharmaceuticals. The company's portfolio includes mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. By integrating AI into its research and development processes, BioNTech aims to enhance the efficiency and effectiveness of its pipeline.
The event will provide an overview of BioNTech’s AI strategy and capabilities, as well as the application of AI in the company's pipeline and internal processes. The live webcast of the event will be available via this link. Participants may also access the slides and a recording of the event via the “Events & Presentations” page in the Investor Relations section of BioNTech’s website at . The recording will be available shortly after the event’s conclusion and archived on BioNTech’s website for one year thereafter.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet